Table 5.

Case series comparing postop ECMO and non-postop ECMO groups in LT patients

Authors	Year	Groups compared	Total LT patients	Postop ECMO	Survival	Comments
Boffini et al. [62]	2019	Postop ECMO vs non-postop ECMO	195	25	1-, 5-year survival ECMO 40%, 30% vs no ECMO 80, 60% On conditional 3-month survival, 1-,5-year survival ECMO 78, 58 vs no ECMO 80, 60	More transfusion, hospital stay
Hartwig et al. [63]	2012	Postop ECMO vs non-postop ECMO (for PGD)	498	28	30-dday, 1-year, 5-year survival ECMO 82%, 64%, 49% No ECMO 97%, 82%, 67%	Freedom from BOS at 3 years 88%, but peak FEV1was 58% in ECMO vs 83% in non-ECMO
Bermudez et al. [64]	2009	Postop ECMO vs non-postop ECMO (for PGD)	763	58	1-year, 5-year survival Postop ECMO 59%, 33% (VA and VV similar) Non-postop ECMO 82%, 54%	Although 67% of ECMO weaned off, long-term survival patients requiring ECMO was inferior
Hartwig et al. [65]	2005		522	23 VA −15 VV- 8	VV ECMO survival similar to no ECMO group	VV ECMO better than VA ECMO—better outcomes and fewer complications
Oto et al. [66]	2004	Early group (1990–1999) Recent group (2000–2003)	481	10	Early group ECMO initiated late—4/4 all died; Recent group ECMO on 0–2 days—3/6 discharged, 1 alive at 1 year
Meyers et al. [67]	2000		444	12	4 not weaned and died. 8 weaned—out of which 1 died